🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.

Platform Response and Material Removal

According to the social media company, the service has taken down problematic material and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.

Within moments of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Product Details and Costs

Inside these groups, messages show black plastic parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has already encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to possibly serious medical dangers”.